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OBJECTIVE — To reveal the inﬂuence of preoperative factors on the prognosis of patients
undergoing percutaneous transluminal angioplasty (PTA) for critical limb ischemia (CLI).
RESEACH DESIGN AND METHODS — We recruited 278 Japanese patients who un-
derwent PTA for CLI between 2003 and 2009. The outcome measures were mortality and major
amputation. Cox proportional hazards regression analyses were performed.
RESULTS — The prevalence of diabetes was 71%, and A1C was 7.0  1.4%. The follow-up
period was 90  72 weeks, and 48 patients underwent major amputations and 89 died. The
presence of diabetes in the whole population and A1C level in the diabetic population had no
inﬂuence on morality; rather, mortality was associated with age (P  0.007), impaired activities
ofdailyliving(P0.001),hemodialysis(P0.001),andalbuminlevel(P0.010).Incontrast,
the presence of diabetes and A1C level had signiﬁcant association with major amputation (P 
0.012 and P  0.007, respectively). The quartile analysis showed that diabetic subjects with an
A1C 6.8%, but not 6.8%, had a signiﬁcantly higher risk of major amputation than nondia-
betic subjects. The adjusted hazard ratio of diabetes with A1C 6.8% was 2.907 (95% CI
1.606–5.264) (P  0.001).
CONCLUSIONS — Diabetes with poor glycemic control is associated with major amputa-
tion, but not mortality, in CLI patients undergoing PTA. Prognostic indicators seem somewhat
different between survival and limb salvage in the population.
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C
ritical limb ischemia (CLI) is a man-
ifestation of peripheral arterial dis-
ease (PAD) that describes patients
with chronic ischemic rest pain or with
ischemic skin lesions, either ulcers, or
gangrene. CLI is associated with an ex-
tremely poor prognosis for both survival
and limb salvage; amputation-free sur-
vival after 1 year is as low as 50%, and
most of the patients ultimately need a re-
vascularization procedure (1).
Recent studies have conﬁrmed the ef-
fectiveness of revascularization with per-
cutaneous transluminal angioplasty
(PTA) for patients with CLI; its outcomes
seem similar to surgical revascularization
even in infrapopliteal segments (2,3). Be-
cause of its minimal invasiveness, PTA is
ideallysuitedeventothoseathighriskfor
bypass surgery, including patients with
diabetes. The increasingly wide applica-
tion of PTA now calls for established pre-
operative risk assessment.
It is well known that CLI has a high
prevalence of diabetes. The presence of
diabetes in the general population and
poor glycemic control in diabetic patients
are associated with infection and delayed
woundhealingaswellasmicro-andmac-
roangiopathy (4–8). Therefore, we
thought that glycemic control may inﬂu-
ence the prognosis of CLI patients.
Fewstudieshave,however,examined
theassociationofpreoperativefactors,in-
cludingdiabeticcondition,withmortality
and limb loss in CLI patients, especially
thoseundergoingPTA(9).Theaimofthis
study was to reveal the inﬂuence of a va-
riety of preoperative factors including di-
abetic condition on their outcome.
RESEARCH DESIGN AND
METHODS— We recruited Japanese
patients who underwent PTA for CLI in
Kansai Rosai Hospital, Hyogo, Japan, be-
tween 2003 and 2009.
All patients with chronic ischemic
rest pain and/or foot ulcer or gangrene
were evaluated for limb ischemia by an-
giography. The diagnosis and manage-
ment of CLI were compliant with the
Transatlantic Inter-Society Consensus
(TASC) (10) or its revised consensus,
TASC II (1). Once they were diagnosed as
having CLI, we utilized PTA as the ﬁrst-
choice procedure for revascularization,
within the recommendations in TASC II.
TheindicationofPTAwasjudgedbycon-
sensusamongvascularspecialists,includ-
ing vascular surgeons. PTA was not
considered to be feasible when lesions
were heavily calciﬁed and/or with diffuse
occlusions, whereas poor-risk patients,
having relative contraindications for by-
pass surgery, those with advanced age,
expectedhighmortalityundergeneralan-
esthesia, and morbidity setting, for in-
stance, would not necessarily be
contraindications for PTA.
Major amputation, namely, above-
the-ankle amputation, was indicated
when revascularization failed to relieve
patients from rest pain or control their
foot lesions. The indication for amputa-
tion was judged by consensus among
plastic surgeons as well as vascular spe-
cialists. Insufﬁcient blood ﬂow even after
revascularizationanduncontrollablelimb
infection were considered to be indica-
tions for amputation.
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of the recruited patients as well as those
with diabetes. The outcome measures
were limb loss by major amputation and
mortality.Thepreoperativevariablescon-
sidered in the analyses were sex, age, ac-
tivities of daily living (ADLs), Fontaine
stage, the presence of infection, diabetic
condition, hypertension, dyslipidemia,
smoking, receiving regular hemodialysis,
and serum albumin level as a nutritional
marker. Diabetic condition was deter-
mined as the presence of diabetes in the
whole population and as a glycemic con-
trol in the diabetic population. The diag-
nosis of diabetes was based on World
HealthOrganizationcriteria,whereasgly-
cemic control of diabetic patients was
evaluated by A1C. Hypertension was di-
agnosed as systolic blood pressure 130
mmHg or diastolic blood pressure 80
mmHg or having been treated for hyper-
tension. Dyslipidemia was deﬁned as se-
rum LDL cholesterol 100 mg/dl or HDL
cholesterol 40 mg/dl or triglycerides
150mg/dlorhavingbeentreatedfordys-
lipidemia. Partial or total dependence in
transferring(requiringsomehelpinmoving
in and out of bed/chair or a complete trans-
fer) were regarded as impaired ADLs.
Statistical analysis
Data are given as means and SDs for con-
tinuous variables or as percentages for di-
chotomous variables. Limb salvage and
survival were plotted using the Kaplan-
Meier method, and, if necessary, the dif-
ferences between the two groups were
assessed by a log-rank test. Cox propor-
tionalhazardsregressionmodelwasusedto
determine the unadjusted association of
each variable with the outcome. The statis-
tically signiﬁcant variables in the univariate
analyses, as well as sex and age, were en-
tered into multivariate models to reveal the
independent impact on the outcome. Haz-
ard ratios (HRs) and 95% CIs are reported.
P0.05 was considered signiﬁcant. Statis-
tical analyses were performed using SPSS
version 15.0J (SPSS, Chicago, IL).
RESULTS— A total of 278 CLI pa-
tients undergoing primary PTA proce-
dures were recruited; aorto-iliac lesions
were revascularized in 23% of the popu-
lation, femoro-popliteal in 63%, and infr-
apoplitealin68%.Baselinecharacteristics
are shown in Table 1. The prevalence of
diabetes was 71%, and their mean A1C
level was 7.0%. Diabetic patients had a
signiﬁcantly higher prevalence of Fon-
taine stage IV and hemodialysis than
those without diabetes (P  0.006 and
P  0.001, respectively).
Follow-up period was 90  72 weeks
(1.7  1.4 years), and 48 patients under-
went major amputations and 89 died. Fig-
ure 1 shows the cause of death and Kaplan-
Meier estimates of major amputation and
mortality. The leading cause of death was
cardiac and vascular disease (n  40); fol-
lowed by infection (n  31), including
pneumonia (n  16), sepsis secondary to
infective gangrene of the foot (n  8), bed
sore infection (n  1), and catheter-related
infection (n  1); and unspeciﬁed causes
(n  5). Diabetic patients had a higher rate
ofmajoramputationcomparedwithnondi-
abetic patients (P  0.008, log-rank test),
whereas they had a similar life prognosis
(P  0.717).
Prognostic factors in the whole
population
Table2showstheinﬂuenceofpreoperative
variables on the prognosis in the whole
population. The presence of diabetes was
independently associated with major am-
putation, and the adjusted HR was 3.101
(95% CI 1.262–7.621) (P  0.014). The
variable had, however, no statistically sig-
niﬁcant inﬂuence on mortality. Rather,
mortalitywasassociatedwithage,impaired
ADLs, hemodialysis, and serum albumin
level;theadjustedHRswere1.036(1.010–
1.063) in the 1-year increment (P0.007)
and 2.302 (1.407–3.605) (P  0.001),
2.699 (1.682–4.332) (P  0.001), and
1.788 (1.150–2.782) in the 1-g/dl decre-
ment (P  0.010), respectively.
Prognostic factors in the diabetic
population
We also performed analyses with a focus
on the patients with diabetes (Table 3).
Here again, mortality was associated with
age, impaired ADLs, hemodialysis, and
serum albumin level. No signiﬁcant asso-
ciation was found between mortality and
A1C level. A1C level was, however, inde-
pendently associated with major amputa-
tion, whose adjusted HR was 1.349 (95%
CI 1.103–1.650) in the 1% increment
(P  0.004). Its association was still sig-
niﬁcantinthemultivariatemodelsinwhich
every other peripheral vascular factor avail-
able in our dataset was substituted for Fon-
taine stage IV (online appendix Table A,
available at http://care.diabetesjournals.
org/cgi/content/full/dc10-0939/DC1).
Next,wedividedtheA1Cdatasetinto
quartiles to analyze the relationship be-
tween the increment of A1C level and the
risk for major amputation in the diabetic
patients. A1C 5.9% was categorized
into the ﬁrst quartile (Q1), 6.0–6.7%
into the second quartile (Q2), 6.8–
7.6% into the third quartile (Q3), and
7.7% into the fourth quartile (Q4). In
a stepwise multivariate model, the
categorized A1C level was indepen-
dently associated with major amputa-
tion,withadjustmentforFontainestage
IV,hemodialysis,andinfection.Thead-
justedHRsofQ2,Q3,andQ4relativeto
Q1 were 2.030 (95% CI 0.657–6.266)
(P  0.218), 3.398 (1.227–9.412) (P 
0.019), and 3.983 (1.398–11.35) (P 
0.010), respectively.
We further analyzed the inﬂuence of
the presence of diabetes on major ampu-
Table 1—Baseline characteristics of the study population
The whole
population
Diabetic
subjects
Nondiabetic
subjects
P value (diabetes
vs. nondiabetes)
n 278 197 81
Male 183 (66) 133 (68) 50 (62) 0.404
Age (years) 71.4  10.5 70.6  9.7 73.3  12.2 0.047
Impaired ADLs 106 (38) 73 (37) 33 (41) 0.589
Fontaine stage IV 228 (82) 170 (86) 58 (72) 0.006
Diabetes 197 (71) — — —
Hypertension 232 (83) 165 (84) 67 (83) 0.860
Dyslipidemia 214 (77) 158 (80) 56 (69) 0.059
Smoking 190 (68) 129 (65) 61 (75) 0.120
Receiving hemodialysis 126 (45) 102 (52) 24 (30) 0.001
Albumin (g/dl) 3.4  0.6 3.5  0.6 3.4  0.7 0.279
A1C (%) — 7.0  1.4 — —
Dataaren(%)ormeansSD.Differencesbetweencontinuousvariablesofdiabeticandnondiabeticgroups
were evaluated by unpaired t tests, whereas dichotomous variables between the two groups were compared
by Fisher exact tests.
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A1C quartile of the diabetic group, de-
ﬁned above, was compared with the non-
diabetic group in a stepwise multivariate
model. As shown in Fig. 2A, the two higher
A1C quartiles of the diabetic group (that is,
the diabetic group with A1C 6.8%) had a
signiﬁcantly higher risk than the nondia-
betic group, whereas the two lower A1C
quartiles (that is, A1C 6.8%) did not.
Basedontheseﬁndings,wereanalyzedwith
substitution of diabetes with A1C 6.8%
for the presence of diabetes in the original
multivariate model shown in Table 2. The
result was that diabetes with A1C 6.8%,
infection, and hemodialysis were signiﬁ-
cantly associated with major amputation;
their adjusted HRs were 2.907 (95% CI
1.606–5.264) (P  0.001), 2.375 (1.198–
4.711) (P  0.014), and 3.530 (1.772–
7.029) (P  0.001), respectively (online
appendix Table B). Note that these three
variables were independent of one an-
other and therefore were expected to
have additive inﬂuences on major am-
putation. In fact, a Kaplan-Meier model
showed that those with the accumula-
tion of these prognostic factors had an
increasedriskofmajoramputation(Fig.
2B). When they had all of these three
Table 2—Association of preoperative variables with the prognosis of CLI patients under-
going PTA
Outcome measures Univariate model Multivariate model
Major amputation
Preoperative variables
Male 1.030 (0.565–1.877) 0.746 (0.400–1.391)
Age (in 1-year increments) 0.983 (0.958–1.009) 0.989 (0.959–1.020)
Impaired ADLs 2.102 (1.191–3.711)* 1.777 (0.972–3.250)
Fontaine stage IV 6.607 (1.603–27.24)† 4.326 (1.028–18.20)*
Infection 2.663 (1.480–4.791)† 2.298 (1.177–4.486)*
Diabetes 2.992 (1.272–7.039)* 3.101 (1.262–7.621)*
Hypertension 0.561 (0.292–1.078) —
Dyslipidemia 0.678 (0.364–1.265) —
Smoking 0.995 (0.540–1.832) —
Receiving hemodialysis 2.778 (1.508–5.117)† 2.875 (1.481–5.582)*
Albumin (in 1-g/dl increase) 0.577 (0.365–0.914)* 0.659 (0.361–1.202)
Mortality
Preoperative variables
Male 1.567 (0.974–2.521) 1.481 (0.902–2.429)
Age (in 1-year increments) 1.027 (1.005–1.049)* 1.036 (1.010–1.063)†
Impaired ADLs 3.272 (2.135–5.013)† 2.302 (1.470–3.605)†
Fontaine stage IV 1.772 (0.975–3.221) —
Infection 2.106 (1.365–3.250)† 1.206 (0.710–2.050)
Diabetes 1.090 (0.683–1.742) —
Hypertension 0.736 (0.447–1.211) —
Dyslipidemia 0.847 (0.519–1.383) —
Smoking 1.100 (0.700–1.729) —
Receiving hemodialysis 2.290 (1.486–3.527)† 2.699 (1.682–4.332)†
Albuimn (in 1-g/dl increment) 0.496 (0.357–0.688)† 0.559 (0.359–0.870)†
Data are HR (95% CI). *P value 0.05; †P value 0.01.
Figure 1—Prognosis of CLI patients undergoing PTA. The cause of death in the whole population (A) and in the population with diabetes (B).
Kaplan-Meier estimates of major amputation (C and D) and survival (E and F) in the whole population. The prognosis was compared between
diabeticpatients(solidline)andnondiabeticpatients(dottedline)inD(P0.008,log-ranktest)andF(P0.717,log-ranktest).CV,cardiacand
vascular disease; MN, malignant neoplasm; DM, diabetes.
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tremely poor. Their estimated median
time to limb loss was only 23 weeks,
which would be rarely different from
naturalcourseofnonrevascularizedCLI
patients (1).
CONCLUSIONS — As is mentioned
in the TASC II (1), a primary outcome in
CLI patients would be amputation-free
survival, although it remains unclear so
far, especially in the population undergo-
ing PTA, which preoperative variables are
associated with their prognosis and
whether morality and limb loss have the
same predictive factors.
In the current study, A1C level was
signiﬁcantlyassociatedwithmajorampu-
tation in patients with diabetes. It is pos-
sible that infection might lead to poor
glycemic control. The multivariate
model, however, showed that A1C level
had a signiﬁcant association with major
amputation independently of infection.
Thecurrentstudyalsoconﬁrmedthat
the presence of diabetes was signiﬁcantly
associated with major amputation in the
whole population and that its signiﬁcant
association was dependent on the glyce-
mic control. Some investigators already
reportedtheassociationbetweendiabetes
and limb loss (11,12), but they did not
take glycemic control into consideration.
We did investigate risk of major amputa-
tion according to glycemic control. In-
terestingly, when compared with nondia-
betes, diabetes A1C 6.8%, but not A1C
6.8%, was signiﬁcantly associated with
major amputation. This ﬁnding suggests
that the increased risk of major amputa-
tion for diabetic patients is mainly attrib-
uted to their poor glycemic control. The
mechanism of association between poor
glycemiccontrolandpoorlimbprognosis
remains unclear. It is well known, how-
ever, that poor glycemic control is associ-
ated with decreased immune response
anddelayedwoundhealing,aswellasthe
progression of microangiopathy includ-
ing neuropathy, all of which play an im-
portant part of foot lesions (13–15); the
existence of poor glycemic control might
reﬂect these underlying conditions.
In discussion of limb prognoses of
PAD patients, the severity of PAD itself
shouldbetakenintoconsideration.There
exist several ways of assessing preopera-
tively their peripheral arterial severity. In
the current study, we adopted Fontaine
stages, a widely used clinical classiﬁca-
tion, and found that it was not signiﬁ-
cantly associated with limb salvage in a
multivariate model, as was poor glycemic
control. To examine this paradoxical re-
sult, we further analyzed with two other
preoperative peripheral arterial factors
available in our dataset, namely ankle-
brachial index, which is physiological,
and runoff below the ankle before PTA,
which is anatomical (or imaging). Yet, the
results were similar; no preoperative pe-
ripheral arterial factors had independent
associationswithlimbloss(onlineappen-
dix Table A). In contrast, a postoperative
variable, the runoff below the ankle after
PTA, was signiﬁcantly associated with
major amputation. One interpretation of
these ﬁndings is that the limb prognosis
depends on the peripheral blood ﬂow af-
ter, rather than before, revascularization.
Figure 2—The association of poor glycemic control and other variables with major amputation.
A: The adjusted HRs for major amputation according to glycemic control. Data are the adjusted
HRsand95%CIsofeachA1Cquartileofthediabeticgrouprelativetothenondiabeticgroupinthe
stepwise multivariate model. They were adjusted for impaired activity of daily living, Fontaine
stage IV, infection, and receiving hemodialysis. The quartiles of A1C were as follows: Q1: 5.9%,
Q2: 6.0–6.7%, Q3: 6.8–7.6%, and Q4: 7.7%. B: Kaplan-Meier estimates of major amputation
accordingtothenumberofriskfactors(P0.001,log-ranktest).Riskfactorsconsideredhereare
the following three variables: diabetes with A1C 6.8%, the presence of infection, and receiving
hemodialysis, all of which had independent associations in the stepwise multivariate Cox propor-
tional hazards regression model. DM, diabetes.
Table 3—Association of preoperative variables for the prognosis with CLI patients with
diabetes undergoing PTA
Outcome measures Univariate model Multivariate model
Major amputation
Preoperative variables
Male 1.242 (0.636–2.427) 1.042 (0.515–2.105)
Age (in 1-year increments) 0.987 (0.957–1.019) 1.010 (0.975–1.046)
Impaired ADL 1.763 (0.957–3.247) —
Fontaine stage IV 4.299 (1.038–17.81)* 3.987 (0.942–16.87)
Infection 2.158 (1.133–4.110)* 2.883 (1.450–5.731)†
Hypertension 0.800 (0.370–1.727) —
Dyslipidemia 0.638 (0.320–1.270) —
Smoking 1.141 (0.593–2.195) —
A1C (in 1% increment) 1.218 (1.006–1.475)* 1.349 (1.103–1.650)†
Receiving hemodialysis 2.434 (1.246–4.757)† 4.176 (1.976–8.825)†
Albumin (in 1-g/dl increment) 0.624 (0.366–1.064) —
Mortality
Preoperative variables
Male 1.328 (0.769–2.293) 1.376 (0.784–2.414)
Age (in 1-year increment) 1.032 (1.005–1.061)* 1.045 (1.012–1.080)†
Impaired ADL 3.124 (1.890–5.163)† 2.514 (1.506–4.197)†
Fontaine stage IV 2.120 (0.952–4.722) —
Infection 1.618 (0.960–2.727) —
Hypertension 0.874 (0.475–1.607) —
Dyslipidemia 0.975 (0.520–1.828) —
Smoking 1.093 (0.650–1.839) —
A1C (in 1% increment) 0.897 (0.742–1.084) —
Receiving hemodialysis 2.082 (1.242–3.490)† 3.046 (1.720–5.395)†
Albumin (in 1-g/dl increment) 0.498 (0.330–0.751)† 0.423 (0.260–0.688)†
Data are HR (95% CI). *P value 0.05; †P value 0.01.
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prove peripheral blood ﬂow and could
lead to avoidance of limb loss, even if the
preoperative peripheral ﬂow is severely
impaired.Theseverityofpreoperativepe-
ripheral ﬂow would not always mean the
similar severity of postoperative periph-
eral ﬂow. Given that peripheral blood
ﬂow can be changed by revascularization
procedures, it is not surprising that limb
prognosis after PTA is associated with
postoperative, rather than preoperative,
peripheral arterial factors.
We also surveyed the inﬂuence of
preoperative variables on survival, which
conﬁrmed that diabetes failed to have a
signiﬁcant association with morality.
Some recent trials (11,12,16–18) likely
supported the absence of this association.
Yet, most studies surveyed CLI patients
undergoing PTA together with those un-
dergoing bypass surgery and/or nonre-
vascularized patients, whereas we limited
ourstudypopulationtothoseundergoing
PTA. In addition, we revealed that A1C
level in diabetic patients had no signiﬁ-
cantassociationwithmortality.Theprog-
nostic factors for mortality were, rather,
age, impaired ADLs, hemodialysis, and
serumalbuminlevel.Thesesigniﬁcantas-
sociations were afﬁrmed even with addi-
tional adjustment for cardiac function or
ejection fraction evaluated with echocar-
diography (online appendix Table C).
Previous reports (9,18,19) investigated
some of these prognostic variables, but
they did not mention nutritional status in
the population. As is well known, malnu-
trition affects life prognosis in various
clinical situations (20,21). We adopted
serum albumin level as a nutritional
marker in the current study because of its
great advantages in ease and cost and its
wide use in clinical practice. It is possible
that serum albumin level is affected by clin-
ical factors other than malnutrition. But we
conﬁrmedtherelationshipbetweenmalnu-
trition and mortality by the analyses with
other nutrition-related markers, such as
lymphocyte count and serum cholinester-
ase level (online appendix Table D).
In conclusion, we investigated the as-
sociation of preoperative variables with
the prognosis of CLI patients undergoing
PTA,whichsuggeststhatprognosticindi-
cators are somewhat different between
survival and limb salvage. Diabetes and
poor glycemic control, for instance, was
signiﬁcantly associated with limb loss but
not mortality. Diabetes with poor glyce-
mic control, infection, and hemodialysis
was independently associated with limb
loss, and the accumulation of these prog-
nostic factors increased the amputation
risk. Especially, those with all of the three
risk factors had such poor limb prognosis
that they might fail to receive a prognostic
beneﬁt of PTA. It is possible, however, that
correction of poor glycemic control by ade-
quate interventions leads to prognostic im-
provement. A further prospective
investigation is required to determine
whether the intervention on glycemic con-
trolsubsequentlyimprovestheirprognosis.
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